Drugs / O-15 water
O-15 water
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03806751 | Feb 2025 → Feb 2027 | — | University of Alabama at Birmingham | Withdrawn | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02992899 Background | Apr 2017 → Sep 2019 | post-traumatic stress disorder | Emory University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [O-15]Water | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03806751 ↗ |
| Known as | 15O-water | “15O-water is used as a radioactive tracer for measuring and quantifying blood flow using positron emission tomography (PET) .” NCT02992899 ↗ |
| Known as | Oxygen-15 labelled water | “Oxygen-15 labelled water is a radioactive variation of regular water, in which the oxygen atom has been replaced by oxygen-15 (15O), a positron-emitting isotope.” NCT02992899 ↗ |
| Modality | Diagnostic / imaging agent | “PET tracer” NCT03806751 ↗ |
| Route | Intravenous | “20 mCi intravenous bolus of H2\[15O\]” NCT02992899 ↗ |